Evidence that the receptor for C4a is distinct from the C3a receptor

Immunopharmacology

Volumn 38, Issue 1-2, 1997, Pages 87-92

  Ames, Robert S ^a   Tornetta, Mark A ^a   Foley, James J ^b   Hugli, Tony E ^c   Sarau, Henry M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Department of Pulmonary Pharmacology   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anaphylatoxin receptors; Anaphylatoxins; C3a; C4a; C5a; Complement

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4A RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENTARY DNA; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR CLONING; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL LINE; CLONING, MOLECULAR; COMPLEMENT C3A; COMPLEMENT C4A; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACROPHAGE-1 ANTIGEN; MICE; MOLECULAR SEQUENCE DATA; NEUTROPHILS; RECEPTORS, COMPLEMENT;

EID: 0031474772     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00079-9     Document Type: Article

References (24)

1. Ames, R.S., Li, Y., Sarau, H.M., Nuthulaganti, P., Foley, J.J., Ellis, C., Zeng, Z.Z., Su, K., Jurewicz, A.J., Hertzberg, R.P., Bergsma, D.J., Kumar, C., 1996. Molecular-cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271, 20231-20234.
2. Boulay, F., Mery, L., Tardif, M., Brouchon, L., Vignais, P., 1991. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30, 2993-2999.
3. Boyum, A., 1968. Isolation of mononuclear cells and granulocytes from human blood. Scan. J. Clin. Lab. Invest. 21 (Suppl. 97), 77-89.
4. Crass, T., Raffetseder, U., Martin, U., Grove, M., Klos, A., Kohl, J., Bautsch, W., 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26, 1944-1950.
5. Daffern, P.J., Pfeifer, P.H., Ember, J.A., Hugli, T.E., 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181, 2119-2127.
6. Ember, J.A., Johansen, N.L., Hugli, T.E., 1991. Designing synthetic superagonists of C3a anaphylatoxin [published erratum appears in Biochemistry 1991 Jun 25; 30(25): 6350]. Biochemistry 30, 3603-3612.
7. Fukuoka, Y., Hugli, T.E., 1990. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. J. Immunol. 145, 1851-1858.
8. Gerard, N.P., Gerard, C., 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
9. Gerard, C., Gerard, N.P., 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775-808.
10. Gorski, J.P., Hugli, T.E., Müller Eberhard, H.J., 1979. C4a: The third anaphylatoxin of the human complement system. Proc. Natl. Acad. Sci. USA 76, 5299-5302.
11. Gorski, J.P., Hugli, T.E., Müller Eberhard, HJ., 1981. Characterization of human C4a anaphylatoxin. J. Biol. Chem. 256, 2707-2711.
12. Grynkiewicz, G., Poenie, M., Tsein, R.Y., 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
13. Hugli, T.E., 1984. Structure and function of the anaphylatoxins. Springer Semin. Immunopathol. 7, 193-219.
14. Hugli, T.E., Gerard, C., Kawahara, M., Scheetz, M.E. 2d, Barton, R., Briggs, S., Koppel, G., Russell, S., 1981. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol. Cell. Biochem. 41, 59-66.
15. Lundberg, C., Gardinali, M., Hugli, T.E., 1987. Complement activation and membrane lipids in lung vascular injury. Am. Rev. Respir. Dis. 136, 459-462.
16. Morgan, B.P., 1994. Clinical complementology: Recent progress and future trends. Eur. J. Clin. Invest. 24, 219-228.
17. Mousli, M., Hugli, T.E., Landry, Y., Bronner, C., 1992. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J. Immunol. 148, 2456-2461.
18. 2-generation by C4a. Immunol. Lett. 36, 301-304.
19. Roglic, A., Prossnitz, E.R., Cavanagh, S.L., Pan, Z., Zou, A., Ye, R.D., 1996. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta. 1305, 39-43.
20. 4 partial agonist activity at leukotriene D4 receptors in differentiated U-937 cells. J. Biol. Chem. 264, 19845-19855.
21. Siraganian, R.P., McGivney, A., Barsumian, E.L., Crews, F.T., Hirata, F., Axelrod, J., 1982. Variants of the rat basophilic leukemia cell line for the study of histamine release. Fed. Proc. 41, 30-34.
22. Tornetta, M.A., Foley, J.J., Sarau, H.M., Ames, R.S., 1977. The mouse anaphylatoxin C3a receptor: Molecular cloning, genomic organization and functional expression. J. Immunol. 158, 5277-5282.
23. Tsuruta, T., Yamamoto, T., Matsubara, S., Nagasawa, S., Tanase, S., Tanaka, J., Takagi, K., Kambara, T., 1993. Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am. J. Pathol. 142, 1848-1857.
24. Vogt, W., 1986. Anaphylatoxins: Possible roles in disease. Complement 3, 177-188.